auriniapharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Aurinia Pharmaceuticals Inc. |
| Description | Investors & Media Careers Contact Us Home About Us Overview Management Team Board of Directors Scientific Advisors Partnering Worldwide Locations Our Focu |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 174.129.30.187 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
auriniapharma.com Valuation
|
US$76,112,663
Last updated: 2023-04-30 05:37:17
auriniapharma.com has Semrush global rank of 139,061. auriniapharma.com has an estimated worth of US$ 76,112,663, based on its estimated Ads revenue. auriniapharma.com receives approximately 8,782,231 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, auriniapharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$76,112,663 |
| Daily Ads Revenue | US$70,258 |
| Monthly Ads Revenue | US$2,107,736 |
| Yearly Ads Revenue | US$25,292,824 |
| Daily Unique Visitors | 585,483 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| auriniapharma.com. | A | 1799 | IP: 174.129.30.187 |
| auriniapharma.com. | A | 1799 | IP: 54.208.101.55 |
| auriniapharma.com. | NS | 3600 | NS Record: ns06.domaincontrol.com. |
| auriniapharma.com. | NS | 3600 | NS Record: ns05.domaincontrol.com. |
| auriniapharma.com. | MX | 3600 | MX Record: 0 auriniapharma-com.mail.protection.outlook.com. |
| auriniapharma.com. | TXT | 3600 | TXT Record: adobe-idp-site-verification=a8c81ef55d8565fa42c7a8461170c5122b6f019457e8a8d96cf1f6126c0c49b0 |
| auriniapharma.com. | TXT | 3600 | TXT Record: docusign=2e92526f-1fe1-451c-b496-7fa297ebbc66 |
| auriniapharma.com. | TXT | 3600 | TXT Record: v=DKIM1\\; t=s\\; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEArQ+CO8flXsXCFDMslg\ \lYPnii8HyysDPUv2pqy9z60di/Pi4CVFev1DmQpaUNZGrdDFhVnnMQOLWgk527D+UEA1/MvxJF3GHTWer3qZx+JeG3aYA0I6o03Y6Dak/H0zg/q4Dykru8utwu+l1eDl\ \sB+PACnmJgoB87nVTsuWu7AP798Xbru3y0XoaOlt9 ZbtNNYbXO23MOmL60A2o314jF+N9p7f26vv/mmgd1Oa5xqxIcpy1y7CdJSV7+PzwZIYqCsG3wLNBgtBjXcSnSpl\ \LFf0JLcrhFtuWrjIPhsgeeunLgwd0y4EWgwxqx2Ft5n2tzxG6IU8TJLEcDQpDkMkojVQIDAQAB |
| auriniapharma.com. | TXT | 3600 | TXT Record: MS=ms34657507 |
| auriniapharma.com. | TXT | 3600 | TXT Record: ZOOM_verify_MdT2AoC1TGiyiTPg20A-FA |
| auriniapharma.com. | TXT | 3600 | TXT Record: v=spf1 IP4:208.81.104.165 include:spf.protection.outlook.com include:servers.mcsv.net include:_spf.salesforce.com include:_spf.psm.knowbe4.com -all |
| auriniapharma.com. | TXT | 3600 | TXT Record: apple-domain-verification=NZ8hi7fGhxAqDGaW |
HtmlToTextCheckTime:2023-04-30 05:37:17
| Investors & Media Careers Contact Us Home About Us Overview Management Team Board of Directors Scientific Advisors Partnering Worldwide Locations Our Focus Our Pipeline Our Medicine Product Patient Safety For Patients/Healthcare Providers Lupus Nephritis (LN) Resources Expanded Access Policy Aurinia Alliance Giving Page Investors & Media Careers Contact Us Investors & Media Careers Contact Us Changing the course of autoimmune disease Inspired by patients. Driven to make an impact. Latest News April 28, 2023 • 6:30am EDT Glass Lewis Recommends Aurinia Shareholders Vote “FOR” ALL Company Director Nominees at 2023 Annual Meeting Read Press Release View All News April 25, 2023 • 11:00am EDT Toni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their Kidneys Read Press Release View All News April 24, 2023 • 6:00am EDT Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 Read Press Release View All News © 2023 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 00:17:46 GMT Server: Apache Location: http://www.auriniapharma.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Content-Type: text/html; charset=UTF-8 Date: Sat, 23 Oct 2021 00:17:46 GMT Expires: Thu, 19 Nov 1981 08:52:00 GMT Location: https://www.auriniapharma.com/ Pragma: no-cache Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 00:17:46 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Content-Type: text/html; charset=UTF-8 |
auriniapharma.com Whois Information
Domain Name: AURINIAPHARMA.COM Registry Domain ID: 1720908524_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.wildwestdomains.com Registrar URL: http://www.wildwestdomains.com Updated Date: 2021-05-17T17:45:03Z Creation Date: 2012-05-16T22:41:24Z Registry Expiry Date: 2023-05-16T22:41:24Z Registrar: Wild West Domains, LLC Registrar IANA ID: 440 Registrar Abuse Contact Email: abuse@wildwestdomains.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS05.DOMAINCONTROL.COM Name Server: NS06.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T13:14:04Z <<< |